tricyclodecane-9-yl-xanthogenate

heparan sulfate proteoglycan 2 ; Homo sapiens







10 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 28802717 Chronic D609 treatment interferes with cell cycle and targets the expression of Olig2 in Glioma Stem like Cells. 2017 Nov 5 1
2 26402860 Inhibition of Phosphatidylcholine-Specific Phospholipase C Interferes with Proliferation and Survival of Tumor Initiating Cells in Squamous Cell Carcinoma. 2015 1
3 22101393 Tricyclodecan-9-yl-xanthogenate (D609) mechanism of actions: a mini-review of literature. 2012 Apr 3
4 20937607 Cerebrospinal fluid phospholipase C activity increases in migraine. 2011 Mar 1
5 19782752 Involvement of phosphatidylcholine-phospholipase C and protein kinase C in peptidoglycan-induced nuclear factor-kappaB activation and cyclooxygenase-2 expression in RAW 264.7 macrophages. 2010 Feb 1
6 19937734 The effects of extracellular nucleotides on [Ca2+]i signalling in a human-derived renal proximal tubular cell line (HKC-8). 2010 Jan 1 2
7 16188211 Signaling and interplay mediated by phospholipases A2, C, and D in LA-N-1 cell nuclei. 2005 Sep-Oct 1
8 10072552 A phosphatidylcholine-specific phospholipase C regulates activation of p42/44 mitogen-activated protein kinases in lipopolysaccharide-stimulated human alveolar macrophages. 1999 Mar 1 1
9 9034754 The antiviral, antitumoural xanthate D609 is a competitive inhibitor of phosphatidylcholine-specific phospholipase C. 1996 4
10 1330325 TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. 1992 Nov 27 1